These data are consistent with previous studies, which found that reductions in novel PKC activation are associated with improved insulin sensitivity in liver and skeletal muscle (25–27), and that increased novel PKC activation is associated with lipid-induced insulin resistance in these tissues (15, 28, 29). The gene discussed is INS; the disease is Insulin resistance.